When I posted the above, I hadn't checked what the issue of the options was for. I wasn't too concerned because the exercise price was above the current sp and above the sp at the time that they were granted. When options have an exercise price at a good premium to the current sp, I know they will only get exercised if we see a strong increase in the sp.
In any case, I was wondering why these were issued. I noticed that the majority of the options (550,000) were issued as part of the convertible note issue. That means that a significant part of this reported, non-cash expense is a one off. Not a recurring, non-cash expense. Again, if they are exercised, the company receives cash of $4 per option exercised. Effectively the same as raising cash in a cr at a strong premium to the current sp. Hardly an operating expense in my book.
The balance of the options in that first table were issued as incentive options mainly to our CEO and the balance to other directors. These have exercise prices between $6 and $10. I'll be more than happy for these to get exercised. Not only will it boost the cash reserves by raising cash at a big premium to the current sp, but I'd say the directors deserve the options if they get the sp above those exercise prices.
- Forums
- ASX - By Stock
- SPA
- Why this non-cash expense is not as important as EBITDA
SPA
spacetalk ltd
Add to My Watchlist
0.00%
!
15.5¢

Why this non-cash expense is not as important as EBITDA, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.30M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 46230 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 59933 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 46230 | 0.155 |
2 | 69149 | 0.145 |
2 | 42863 | 0.140 |
1 | 55555 | 0.135 |
2 | 26307 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 59933 | 2 |
0.170 | 58348 | 1 |
0.180 | 40000 | 1 |
0.190 | 41806 | 1 |
0.195 | 50000 | 1 |
Last trade - 10.04am 07/07/2025 (20 minute delay) ? |
Featured News
SPA (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online